SHPD vs ACET โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ACET Captures Institutional Edge (2โ2 Pillars ยท 6โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Adicet Bio, Inc. Common Stock (ACET) driven by superior Valuation, Growth & Margin while SHPD counters with relative strength in Momentum & Technical, Options & Structure. Fundamentally, SHPD trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus ACET at N/M Forward P/E and 0.0% operating margin (-100.0% YoY). In options structure, SHPD sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ACET sits in BREAKDOWN (6th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | SHPD | ACET | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | $26.0M | Larger Scale | ACET |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | N/A | -100.0% | Higher Growth | ACET |
| Operating Margin (TTM) Profitability | N/A | 0.0% | Higher Margin | ACET |
| Net Profit Margin Profitability | N/A | 0.0% | Higher Margin | ACET |
| Return on Equity (ROE) Capital Efficiency | N/A | -85.9% | Higher ROE | ACET |
| 52-Week Range Position Momentum | 78% ($16โ$26) | 24% ($0โ$10) | Stronger Trend | SHPD |
| Beta / 30D Volatility Risk Regime | -2.40ฮฒ ยท 48% Vol | 1.90ฮฒ ยท 45% Vol | Lower Realized Risk | ACET |
| Unified Institutional Score Composite Signal | 60.0 / 100 (BUY) | 46.7 / 100 (HOLD) | Higher Composite | SHPD |